GLP-1-based and related injectable therapies are FDA-approved prescription medications designed to support medically supervised weight loss by mimicking natural hormones that regulate appetite, digestion, and insulin levels
In the OASIS-1 study, 13% of participants (people with obesity without diabetes) receiving oral semaglutide 50 mg experienced altered skin sensation events compared to 1% with placebo - these events were generally mild to moderate in severity, occurred during dose escalation to the higher doses and resolved without requiring permanent treatment discontinuation [21]
What Users Experience Users who inject Melanotan II before bed commonly report: Faster sleep onset (falling asleep more quickly) Yawning and stretching within 30 to 60 minutes of injection Deeper subjective sleep quality More vivid dreams (reported by some users) It's important to distinguish between a genuine sleep benefit and the practical advantage of "sleeping through side effects." Many practitioners recommend bedtime dosing specifically so patients don't experience nausea and flushing during waking hours
[3] Di Paola R, Modafferi S, Siracusa R, Cordaro M, D'Amico R, Ontario ML, Interdonato L, Salinaro AT, Fusco R, Impellizzeri D
INJECTION Injection: 3 mL per 100 kg bodyweight (15 mL per average horse) by intravenous or intramuscular injection 2 - 3 times weekly
On a U-100 syringe, 1 unit = 0.1 mg (100 mcg)
